Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
The FDA granted approval of Dovato to ViiV Healthcare
April 8, 2019 Off

The FDA granted approval of Dovato to ViiV Healthcare

By Dino Mustafić

The U.S. Food and Drug Administration Monday approved Dovato, two-drug, fixed-dose, complete regimen for HIV-infected adults who have never received treatment for HIV.

Tricida Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 8, 2019 Off

Tricida Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

By BusinessWire

Tricida has closed public offering of common stock and full exercise of underwriters’ option to ourchase additional shares

SAKURA 3 Trial Results Presented on Podium at World’s Largest Medical Aesthetic Conference
April 8, 2019 Off

SAKURA 3 Trial Results Presented on Podium at World’s Largest Medical Aesthetic Conference

By BusinessWire

Unprecedented clinical results for DaxibotulinumtoxinA for Injection(DAXI), Revance’s long-acting neuromodulator, were highlighted at the 17thAesthetics & Anti-Aging Medical World Congress in Monte-Carlo

April 8, 2019 Off

Medpace Holdings, Inc. to Report First Quarter 2019 Financial Results on April 29, 2019

By BusinessWire

CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2019 financial results after…

Brief: Unither Therapeutics drops esuberaprost tablets development for pulmonary arterial hypertension
April 8, 2019 Off

Brief: Unither Therapeutics drops esuberaprost tablets development for pulmonary arterial hypertension

By Dino Mustafić

United Therapeutics Corporation Monday said that the BEAT clinical study of esuberaprost tablets in patients suffering from pulmonary arterial hypertension did not meet its primary endpoint of delayed time to first clinical worsening event.

Azitra Demonstrates Feasibility of Engineering the Skin Microbiome to Treat Serious Skin Conditions
April 8, 2019 Off

Azitra Demonstrates Feasibility of Engineering the Skin Microbiome to Treat Serious Skin Conditions

By BusinessWire

Azitra will be presenting results from the joint researchshowing the successful genetic engineering of the common skin bacterium, Staphylococcusepidermidis, to produce high levels of functional LEKTI protein, aprotease inhibitor involved in regulating the rate of skin loss.

SmithRx First PBM to Publicly Support HHS Proposal to End PBM Rebates in Medicare and Medicaid
April 8, 2019 Off

SmithRx First PBM to Publicly Support HHS Proposal to End PBM Rebates in Medicare and Medicaid

By BusinessWire

SAN FRANCISCO–(BUSINESS WIRE)–SmithRx, a San Francisco based technology company and Pharmacy Benefit Manager (PBM), today released the company’s public comment…

OTITOPIC™ Pursues Additional New Indication for Dry Powder Inhalation of Aspirin as a Treatment for Non-Small-Cell Lung Cancer (NSCLC)
April 8, 2019 Off

OTITOPIC™ Pursues Additional New Indication for Dry Powder Inhalation of Aspirin as a Treatment for Non-Small-Cell Lung Cancer (NSCLC)

By BusinessWire

The new treatment can potentially provide benefits superior to other commontherapies greatly improving clinical outcomes for patients being treatedfor lung cancer.

April 8, 2019 Off

Cough Pipeline Review, H1 2019 by Stage of Development, Drug Target, MoA, RoA and Molecule Type – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Cough – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Cough – Pipeline Review,…

April 8, 2019 Off

Global eClinical Solutions Market Size, Share & Trends Analysis 2014-2019 & 2026 by Product, Delivery Mode, Development Phase, End Use, And Segment Forecasts – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “eClinical Solutions Market Size, Share & Trends Analysis Report By Product (CTMS, ECOA, EDC, CDMS, RTSM, eTMF), By…

Posts pagination

Previous 1 … 3,291 3,292 3,293 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine